Schedule 13D ownership disclosure
PetLife Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 71639C103
Event date: 2017-03-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.4300%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001477932-17-001629
- Form type
- SC 13D
- Filer
- PetLife Pharmaceuticals, Inc.
- CIK
- CIK 1354591
- Filed
- Apr 07, 2017
- Reporting period
- Mar 28, 2017
- Description
- Schedule 13D beneficial ownership